Nightstar Therapeutics plc American Depositary Shares
NITE
NITE was delisted on the 6th of June, 2019.
36 hedge funds and large institutions have $218M invested in Nightstar Therapeutics plc American Depositary Shares in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 8 closing their positions.
163% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 8
69% more capital invested
Capital invested by funds: $129M → $218M (+$89.1M)
57% more funds holding
Funds holding: 23 → 36 (+13)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$31.3M |
| 2 |
DM
Deerfield Management
New York
|
+$10.3M |
| 3 |
WIM
Woodford Investment Management
London,
United Kingdom
|
+$7.56M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$6.06M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$5.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$16.3M |
| 2 |
AC
Ascend Capital
Orinda,
California
|
-$2.43M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.85M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.22M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.19M |
NITE Hedge Fund Activity: Q3 2018 in Review
36 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q3 2018, worth a combined $218M — up 69% from $129M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NITE positions and 8 closed out — a net gain of 13 holders — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $31.3M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $16.3M sold.
- 36 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q3 2018, up from 23 in Q2 2018.
- Funds reported $218M of Nightstar Therapeutics plc American Depositary Shares stock for Q3 2018, up 69% quarter-over-quarter.
- 21 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q3 2018 and 8 closed out, a net change of +13 holders.
- The largest Nightstar Therapeutics plc American Depositary Shares buyer in Q3 2018 was Point72 Asset Management, an estimated $31.3M added.
- The largest Nightstar Therapeutics plc American Depositary Shares seller in Q3 2018 was PFM Health Sciences, an estimated $16.3M sold.
Based on aggregated 13F filings for Q3 2018.